792 Results

People

  1. Kemeny
    Kemeny
  2. Kris
    Kris
  3. De Angelis
    De Angelis
  4. Giralt
    Giralt
  5. Usmani
    Usmani
  6. Landau
    Landau
  7. Hassoun
    Hassoun
  8. Yahalom
    Yahalom
  9. Comenzo
    Comenzo
  10. Posner
    Posner

Groups

  1. Department of Medicine (421)
  2. Hematologic Malignancies, Division of (207)
  3. Solid Tumor Oncology Division (206)
  4. Center for Hematologic Malignancies (205)
  5. Survivorship Research (119)
  6. Gastrointestinal Oncology Service (92)
  7. Center for Pancreatic Cancer Research (65)
  8. Surgery (65)
  9. Bone Marrow Transplant (61)
  10. Sloan Kettering Institute Faculty (60)
  1. "dexamethasone"
Formats
  1. Journal Article (719)
  2. Review (25)
  3. Conference Paper (14)
  4. Research Letter (13)
  5. Meeting Abstract (6)
  6. Correspondence (5)
  7. Editorial (5)
  8. Guidelines (4)
  9. Book Section (1)
Groups
  1. Department of Medicine (421)
  2. Hematologic Malignancies, Division of (207)
  3. Solid Tumor Oncology Division (206)
  4. Center for Hematologic Malignancies (205)
  5. Survivorship Research (119)
  6. Gastrointestinal Oncology Service (92)

More Groups

People
  1. Nancy Kemeny (66)
  2. Mark Kris (43)
  3. Lisa De Angelis (33)
  4. Saad Usmani (32)
  5. Sergio Giralt (32)
  6. Heather Landau (27)

More People

Years
  1. 2025 (23)
  2. 2024 (48)
  3. 2023 (34)
  4. 2022 (23)
  5. 2021 (9)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (56)
  2. Journal of the National Comprehensive Cancer Network (31)
  3. Cancer (27)
  4. Blood (23)
  5. Seminars in Oncology (21)
  6. British Journal of Haematology (18)

More Publications

Publishers
  1. Elsevier Inc. (130)
  2. American Society of Clinical Oncology (59)
  3. Lippincott Williams & Wilkins (48)
  4. Springer (44)
  5. Wiley Blackwell (44)
  6. Nature Publishing Group (43)

More Publishers

Results (792)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined hepatic arterial infusion pump and systemic chemotherapy in the modern era for chemotherapy-naive patients with unresectable colorectal liver metastases
    Journal Article

    Verheij, F. S.; Kuhlmann, K. F. D.; Silliman, D. R.; Soares, K. C.; Kingham, T. P.; Balachandran, V. P.; Drebin, J. A.; Wei, A. C.; Jarnagin, W. R.; Cercek, A.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Sepsis and adrenal insufficiency
    Review

    Fowler, C.; Raoof, N.; Pastores, S. M.
    Journal of Intensive Care Medicine (2023)

    Fulltext@MSK | Save
  • Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): Final analysis of an open-label, randomised, phase 2 trial
    Journal Article

    Voorhees, P. M.; Sborov, D. W.; Laubach, J.; Kaufman, J. L.; Reeves, B.; Rodriguez, C.; Chari, A.; Silbermann, R.; Costa, L. J.; Anderson, L. D. Jr; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma
    Journal Article

    Villa, D.; Jiang, A.; Visco, C.; Crosbie, N.; McCulloch, R.; Buege, M. J.; Kumar, A.; Bond, D. A.; Paludo, J.; Maurer, M. J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy
    Research Letter

    Mohan, M.; Janz, S.; Brazauskas, R.; Dwinell, M. B.; Teng, B. Q.; Yun, G.; Dong, J.; Pasquini, M. C.; Giralt, S.; Landau, H.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responses
    Journal Article

    Maximova, O. A.; Weller, M. L.; Krogmann, T.; Sturdevant, D. E.; Ricklefs, S.; Virtaneva, K.; Martens, C.; Wollenberg, K.; Minai, M.; Moore, I. N.; more...
    PLoS Pathogens (2023)

    Fulltext@MSK | Save
  • Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal antibody resistant variants
    Research Letter

    Kamboj, M.; Laracy, J. C.; Usiak, S.; Babady, N. E.; Yan, J.; Seo, S. K.
    Journal of Infection (2023)

    Fulltext@MSK | Save
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
    Journal Article

    Wudhikarn, K.; Tomas, A. A.; Flynn, J. R.; Devlin, S. M.; Brower, J.; Bachanova, V.; Nastoupil, L. J.; McGuirk, J. P.; Maziarz, R. T.; Oluwole, O. O.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Report of consensus panel 7 from the 11th International Workshop on Waldenström Macroglobulinemia on priorities for novel clinical trials
    Conference Paper

    Tam, C. S.; Kapoor, P.; Castillo, J. J.; Buske, C.; Ansell, S. M.; Branagan, A. R.; Kimby, E.; Li, Y.; Palomba, M. L.; Qiu, L.; more...
    W.B. Saunders Co-Elsevier Inc. (2023)

    Fulltext@MSK | Save